-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FfK8x26xwXIbCli6lM5qnboyqBzr/a30hwShIGMyZNsgASpNPzEUTqwEejIb2C+f fFn/9dOz8wjZFRyF0wle6g== 0001144204-07-010905.txt : 20070302 0001144204-07-010905.hdr.sgml : 20070302 20070302060110 ACCESSION NUMBER: 0001144204-07-010905 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070302 DATE AS OF CHANGE: 20070302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN LABORATORIES INC CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-09114 FILM NUMBER: 07665512 BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 8-A12B 1 v067315_8a12b.htm
 
 
FORM 8-A

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO
SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE
ACT OF 1934

Mylan Laboratories Inc.
(Exact name of registrant as specified in its charter)

Pennsylvania
(State of incorporation or organization)
  
25-1211621
(IRS Employer
Identification No.)
 
1500 Corporate Drive, Canonsburg, Pennsylvania
(Address of principal executive offices)
  
15317
(zip code)
 
Securities to be registered pursuant to Section 12(b) of the Act:
    
 
Title of each class
to be so registered
  
Name of each exchange on which
each class is to be registered
 
1.25% Senior Convertible Notes due 2012
  
 
New York Stock Exchange, Inc.

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ý
 
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨
 
Securities Act registration statement file number to which this form relates:  333-140778
 
Securities to be registered pursuant to Section 12(g) of the Act:  None
 


INFORMATION REQUIRED IN REGISTRATION STATEMENT
 

 
 
Item 1.  Description of Registrant’s Securities to be Registered.
 
This registration statement on Form 8-A relates to $550,000,000 principal amount of 1.25% Senior Convertible Notes due 2012 (the "Senior Convertible Notes") of Mylan Laboratories Inc. (the "Company"), as guaranteed by certain of the Company’s subsidiaries. A description of the Senior Convertible Notes is contained in a Prospectus Supplement filed by the Company with the Securities and Exchange Commission (the “Commission”) pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on March 1, 2007. Such Prospectus Supplement shall supplement the Prospectus contained in the Company's automatically effective Registration Statement on Form S-3 (File No. 333-140778), which became effective upon filing with the Commission on February 20, 2007. Such Prospectus Supplement shall be deemed to be incorporated by reference herein for all purposes.
 
Item 2.  Exhibits
 
A list of exhibits filed herewith is contained in the Exhibit Index following the signature page hereto and is incorporated by reference herein.
 

 





SIGNATURE
 
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Company has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
 

 
MYLAN LABORATORIES INC.
(Registrant)
 
 
Date: March 1, 2007
 
By: /s/ Daniel C. Rizzo, Jr.
Name: Daniel C. Rizzo, Jr.
Title: Vice President and Corporate Controller
 


Exhibit Index
 
 
3.1
Amended and Restated Articles of Incorporation of the Company, as amended, filed as Exhibit 3.1 to Form 10-Q for the quarter ended June 30, 2003, and incorporated by reference herein.
 
 
3.2
Second Amended and Restated Bylaws of the Company, as amended to date, filed as Exhibit 3.1 to the Report on Form 8-K filed with the SEC on February 22, 2005, and incorporated by reference herein.
 
 
4.1
Form of global certificate evidencing the Senior Convertible Notes filed as Exhibit 4.8 to the Company’s Registration Statement on Form S-3, filed with the Commission on February 20, 2007, and incorporated by reference herein.
 
 
4.2
Form of indenture for the Senior Convertible Notes, to be entered into among the Company, the guarantors named therein and The Bank of New York, as trustee, filed as Exhibit 4.9 to the Company’s Registration Statement on Form S-3, filed with the Commission on February 20, 2007, and incorporated by reference herein.
 

 
 -----END PRIVACY-ENHANCED MESSAGE-----